{"id":"W3100553135","doi":"10.1016/j.annonc.2020.10.596","title":"Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":163,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; F. Hoffmann-La Roche","keywords":"Fulvestrant; Medicine; Placebo; Hazard ratio; Internal medicine; Breast cancer; Clinical endpoint; Oncology; Aromatase inhibitor; Metastatic breast cancer; Cancer; Estrogen receptor; Randomized controlled trial; Gynecology; Confidence interval; Aromatase; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001179269,0.00204005,0.003283111,0.0003492466,0.0003519303,0.001347921,0.001031455,0.001399896,0.007727724],"category_scores_gemma":[0.00126257,0.0006573448,0.002136483,0.0003948727,0.001201467,0.001198788,0.0003948544,0.003595659,0.001454813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001060601,"about_ca_system_score_gemma":0.00108141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001575292,"about_ca_topic_score_gemma":0.0043912,"domain_scores_codex":[0.9996872,0.0001388977,0.00001190254,0.00006407461,0.00001996681,0.00007794418],"domain_scores_gemma":[0.9995,0.0001238804,0.0001045918,0.00005801025,0.00002276429,0.0001906791],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9789742,0.002804303,0.0003985514,0.0003705861,0.001182202,0.00003557606,0.0000344464,0.0006949354,0.001938875,0.0002204814,0.001683612,0.01166215],"study_design_scores_gemma":[0.9759243,0.02121984,0.001009022,0.00001566294,0.000403311,0.00002693761,0.00002016501,0.0004182275,0.0001984073,0.0002296697,0.0005209902,0.00001345371],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819018,0.005942497,0.00091027,0.001608098,0.001006118,0.00197429,0.002638188,0.0003483657,0.003670463],"genre_scores_gemma":[0.9785338,0.003699052,0.001612539,0.002211124,0.0005339059,0.00273288,0.002948123,0.00006785354,0.007660737],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007727724,"threshold_uncertainty_score":0.02585179,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03981314504028136,"score_gpt":0.3696024707202757,"score_spread":0.3297893256799943,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}